Suggestions
Sheena Liu
Founder and CEO at Medebound. Physician Entrepreneur. Columbia PhD, ex-Philips, ex-Boeringer Ingelheim
Sheena Liu is the Co-Founder and CEO of MedeboundHEALTH, a global telehealth company focused on connecting patients worldwide with top medical experts in the United States.12
Professional Background
Dr. Liu has an impressive medical and academic background:
- She holds an M.D. degree
- She earned a Ph.D. in Biomedical Informatics from Columbia University2
Prior to founding MedeboundHEALTH, Dr. Liu held several notable positions:
- Team Lead at Royal Philips
- Director of Informatics at Boehringer Ingelheim, a major pharmaceutical company
- Managed a high-profile informatics program collaborating with over 100 top US hospitals2
Entrepreneurial Journey
In 2015, Dr. Liu launched Medebound, which later became MedeboundHEALTH.1 The company's mission is to provide patients globally with access to the best possible care, regardless of their location.3 Under her leadership, MedeboundHEALTH has achieved significant milestones:
- Contracted with some of the world's largest insurance companies
- Grown its membership to over two million lives
- Developed a HIPAA-compliant telemedicine platform for seamless data transfer between patients and US physicians2
Recognition
Dr. Liu's efforts in healthcare innovation have not gone unnoticed. In 2021, Forbes recognized MedeboundHEALTH among the top 52 women-led startups driving the future of healthtech and femtech.2
Vision and Approach
Dr. Liu's focus is on creating "a virtual bridge" to connect Chinese patients with quality healthcare in the US and Europe.1 Her company's approach has led to impressive results:
- Improved treatment plans for 75% of consultations
- Changed diagnoses completely in 22% of cases
- Suggested less invasive alternatives or no need for surgery in 25% of cases2
Through strategic partnerships, such as with Castle Connolly Top Doctors and Ping An Healthcare Diagnostic Center, Dr. Liu continues to expand MedeboundHEALTH's reach and impact in global healthcare.13